GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Haoyuan Chemexpress Co Ltd (SHSE:688131) » Definitions » Debt-to-Equity

Shanghai Haoyuan Chemexpress Co (SHSE:688131) Debt-to-Equity : 0.66 (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Shanghai Haoyuan Chemexpress Co Debt-to-Equity?

Shanghai Haoyuan Chemexpress Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ¥659 Mil. Shanghai Haoyuan Chemexpress Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ¥1,247 Mil. Shanghai Haoyuan Chemexpress Co's Total Stockholders Equity for the quarter that ended in Dec. 2024 was ¥2,878 Mil. Shanghai Haoyuan Chemexpress Co's debt to equity for the quarter that ended in Dec. 2024 was 0.66.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Shanghai Haoyuan Chemexpress Co's Debt-to-Equity or its related term are showing as below:

SHSE:688131' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.06   Med: 0.3   Max: 0.66
Current: 0.66

During the past 12 years, the highest Debt-to-Equity Ratio of Shanghai Haoyuan Chemexpress Co was 0.66. The lowest was 0.06. And the median was 0.30.

SHSE:688131's Debt-to-Equity is ranked worse than
75.27% of 825 companies
in the Drug Manufacturers industry
Industry Median: 0.28 vs SHSE:688131: 0.66

Shanghai Haoyuan Chemexpress Co Debt-to-Equity Historical Data

The historical data trend for Shanghai Haoyuan Chemexpress Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Haoyuan Chemexpress Co Debt-to-Equity Chart

Shanghai Haoyuan Chemexpress Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.33 0.11 0.28 0.42 0.66

Shanghai Haoyuan Chemexpress Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.42 0.43 0.43 0.48 0.66

Competitive Comparison of Shanghai Haoyuan Chemexpress Co's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Haoyuan Chemexpress Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Haoyuan Chemexpress Co's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Haoyuan Chemexpress Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Shanghai Haoyuan Chemexpress Co's Debt-to-Equity falls into.


;
;

Shanghai Haoyuan Chemexpress Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Shanghai Haoyuan Chemexpress Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Shanghai Haoyuan Chemexpress Co's Debt to Equity Ratio for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Haoyuan Chemexpress Co  (SHSE:688131) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Shanghai Haoyuan Chemexpress Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Shanghai Haoyuan Chemexpress Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Haoyuan Chemexpress Co Business Description

Traded in Other Exchanges
N/A
Address
No. 2, Lane 720, Cailun Road, Room 501, Pilot Free Trade Zone, Shanghai, CHN, 201203
Shanghai Haoyuan Chemexpress Co Ltd focuses on providing small molecule and new modalities CDMO services for both pharmaceutical and biotech clients. The company's comprehensive CRO & CDMO platform is engaged in the research and development, manufacturing and supply of regulatory starting materials, novel building blocks, intermediates, reference compounds, APIs and drug products. It is a one-stop service platform to support client's projects from early drug discovery, process development to commercialization. The company is committed to delivering high-quality products and CMC services to clients across the entire life cycle of drug development.
Executives
Mei Kui Core technical personnel

Shanghai Haoyuan Chemexpress Co Headlines

No Headlines